Abstract | BACKGROUND: METHODS: We report three patients who developed macroglossia and dysautonomia of central neurogenic origin following brainstem injury. RESULTS: CONCLUSIONS:
|
Authors | Ifeanyi Iwuchukwu, Agnieszka Ardelt, Wilson Cueva, Rwoof Reshi, Fernando Goldenberg, Jeffrey Frank |
Journal | Neurocritical care
(Neurocrit Care)
Vol. 20
Issue 1
Pg. 106-10
(Feb 2014)
ISSN: 1556-0961 [Electronic] United States |
PMID | 24002892
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Adrenergic beta-Antagonists
- Amines
- Anti-Inflammatory Agents
- Calcium Channel Blockers
- Cyclohexanecarboxylic Acids
- gamma-Aminobutyric Acid
- Gabapentin
- Dexamethasone
|
Topics |
- Adolescent
- Adrenergic beta-Antagonists
(therapeutic use)
- Aged
- Amines
(therapeutic use)
- Anti-Inflammatory Agents
(therapeutic use)
- Brain Injuries
(complications, etiology)
- Brain Stem
(injuries)
- Calcium Channel Blockers
(therapeutic use)
- Cranial Fossa, Posterior
(injuries)
- Cyclohexanecarboxylic Acids
(therapeutic use)
- Dexamethasone
(therapeutic use)
- Female
- Gabapentin
- Humans
- Macroglossia
(drug therapy, etiology, surgery)
- Male
- Middle Aged
- Primary Dysautonomias
(drug therapy, etiology)
- Tracheostomy
(methods)
- Treatment Outcome
- gamma-Aminobutyric Acid
(therapeutic use)
|